Metabolic-Fit / 100
Mevo Health review
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Prices and terms come from the company's own published pages. This is background reading, not medical advice.
A Delaware-registered program naming four real physicians, with semaglutide and tirzepatide each offered as an injection or oral tablet from a disclosed floor price ($199/$259 'as low as') — but no full pricing ladder, no state list, and no confirmation the required consult is included.
- Confirm HSA / FSA coverage
- Public information reviewed
- Confirm your total cost
Mevo Health at a glance
- Semaglutide
- As low as $199/mo
- Tirzepatide
- As low as $259/mo
- Coverage
- Not disclosed
- Brand-name
- Compounded only
How we scored Mevo Health
Every factor comes from Mevo Health's own published pricing, disclosures and oversight, and the six combine into the 37/100 Metabolic-Fit Score on our weighted six-factor framework. Commissions don't change a provider's score.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Oversight and lab support fall short of the best on our list — the review below says exactly where.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we checked this review
Public product cards still say semaglutide as low as $199 and tirzepatide as low as $259. These are advertised floors, without a full dose ladder.
Before you sign up
What Mevo Health's public site and signup page show before you hand over any details.
Worth knowing
- The intake runs on Bask Health rather than on the provider's own software
- A monthly price is visible on the public homepage before any intake — you do not have to hand over information to see a number
Pricing
| Medication | Price | Plan |
|---|---|---|
| Compounded semaglutide | $199 | Injection, floor priceAdvertised as 'As low as $199/mo' — a floor price only; no full per-dose ladder is disclosed. |
| Compounded tirzepatide | $259 | Injection, floor priceAdvertised as 'As low as $259/mo' — a floor price only; no full per-dose ladder is disclosed. |
| Oral semaglutide | $199 | Tablet, floor priceAlso offered as an oral tablet at the same 'as low as' floor as the injection. |
| Oral tirzepatide | $259 | Tablet, floor priceAlso offered as an oral tablet at the same 'as low as' floor as the injection. |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what Mevo Health's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- Names four real, checkable physicians rather than hiding behind generic 'licensed provider' language
- Both molecules offered as an oral tablet, not just injection
- A distinct, confirmed Delaware LLC — not an anonymous storefront
- LegitScript seal confirmed present
The caveats
- Only a floor ('as low as') price is disclosed — the real ladder and your actual cost aren't public
- No state-availability list published anywhere
- A consultation is required, but whether it's included in the price or billed separately isn't stated
- Two of its four named physicians also appear on other DTC telehealth brands' sites — an ordinary industry pattern, but worth knowing before assuming Mevo Health's team is exclusive to it
Both formulations use advertised starting floors
Mevo Health advertises semaglutide as low as $199 per month and tirzepatide as low as $259, with injections and oral tablets appearing at the same respective floors. Those figures help identify the options, but they do not establish a complete dose ladder, identical treatment costs for every patient or equivalence between the oral and injectable formulations.
Ask which prescription, quantity and term qualify for the starting amount, then obtain the renewal charge for that actual plan. A shared price does not establish a shared supply duration or clinical effect. Someone considering a tablet should request its own product explanation rather than carrying an injection’s dose, instructions or evidence into a different route.
Consultation is required, while its cost is unresolved
Mevo says prescription products require an online consultation. The public information does not establish whether that clinical review is included in the medication amount or billed separately. Clarify the charge before comparing $199 or $259 with another service that expressly includes care or adds a separate membership.
The written quote should also identify supplies, delivery and continuing contact. Ask what happens if additional assessment is needed, a prescription changes or the patient is not approved. A requirement for clinical review is meaningful, but it does not by itself establish a particular appointment format, an immediate prescribing decision or an unconditional refund promise.
The named provider network is useful context
Mevo identifies four physicians, led by Dr. David Wasef, alongside Dr. Frank Suppa, Dr. Andrew Sakla and Dr. Constantin Chikando. Those names give a prospective patient more to investigate than a completely anonymous network. They do not establish which individual reviews every application or that the same professional provides all continuing care.
Some of the physicians also appear on other telehealth brands’ sites. That overlap should not be treated as proof of common ownership or a duplicate company. It can matter to someone seeking an independent clinical relationship, however. Ask which medical practice holds the records and how the assigned clinician can be contacted rather than assuming a different storefront guarantees a different team.
Pharmacy and state identities remain important gaps
Mevo identifies Mevo Health LLC and describes using U.S. 503A compounding pharmacies, without publicly naming the actual dispensing partners. Obtain the pharmacy for the selected prescription and its contact details. A legal company name identifies the seller; a pharmacy category does not tell the patient which licensed facility prepares the product.
No state-availability list or clear all-state claim is published in its public information. Confirm both clinical and pharmacy access for the intended location before relying on a product card. For the compounded medication, request ingredients, concentration, quantity, storage and instructions, keeping the finished product’s nonapproved status distinct from any familiar brand-name active ingredient.
Certification presentation does not replace follow-up detail
Mevo displays a LegitScript seal in several locations. Check the applicable current certification record rather than treating the repeated badge as independent evidence of clinical quality. The practical care questions remain how assessments are conducted, whether live discussion is available and what response route exists for medication concerns between orders.
Mevo may interest someone wanting a named physician network and both oral and injectable choices. Its public material does not establish dedicated postpartum, breastfeeding or PCOS support, and its starting floors leave the complete cost unresolved. A clear decision requires the actual consultation charge, prescription-specific renewal amount, pharmacy and state confirmation, plus written stopping terms. The identifiable network is helpful, but it should lead to those answers rather than substitute for them.
The bottom line for mothers
Best for: Mothers who want an oral tablet option and are comfortable getting an exact price in writing before committing, rather than seeing a full ladder published upfront.
Alternatives to Mevo Health
These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.
- Visit CoreAge Rx86
Metabolic-Fit / 100
CoreAge RxFeatured partnerCoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.
- Visit Strut Health80
Metabolic-Fit / 100
Physician-founded and genuinely cheap, with both molecules in a lozenge or a shot and a free MD visit — but a February 2026 FDA misbranding letter is a caveat a mother should read before signing up.
- Visit Willow66
Metabolic-Fit / 100
Unusually open about its clinicians and pharmacies — a named CMO, roughly forty-five named physicians, three named compounding pharmacies — and unusually loose about its advertising, having dropped 'comparable to FDA-approved semaglutide' claims only after the National Advertising Division referred it to the FTC.
Providers like Mevo Health
Keep comparing Mevo Health
Head-to-head & alternatives
Ranked boards
- Best GLP-1 for women
- Best GLP-1 for PCOS & insulin resistance
- Best GLP-1 for perimenopause
- Best GLP-1 while breastfeeding (safety-first)
- Cheapest GLP-1 programs
- Compounded tirzepatide providers
- Cheapest tirzepatide online
- Cheapest semaglutide online
- Where to get Zepbound online
- Semaglutide vs tirzepatide: which is right for you
Mevo Health, answered
- How much does Mevo Health actually cost?
- Only a floor price is disclosed: 'as low as $199/mo' for semaglutide and 'as low as $259/mo' for tirzepatide, injection or oral tablet at the same floor. No full per-dose ladder is published, so your actual price depends on what a provider prescribes — get it in writing before you commit.
- Who prescribes at Mevo Health?
- Four named physicians, led by Dr. David Wasef, plus Dr. Frank Suppa, Dr. Andrew Sakla, and Dr. Constantin Chikando. Two of them also appear on other DTC telehealth brands' sites — a common industry pattern of physicians working across multiple platforms, not a sign Mevo Health is the same company as those brands.
- Which states does Mevo Health serve?
- Not published. There's no state-availability table and no '50 states' claim anywhere on the site — confirm directly before starting intake.
Pricing, states and verification reflect Mevo Health's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.